脊髓损伤药物市场：按药物类型、适应症、应用、给药途径、配销通路和地区

预计2023年，脊髓损伤药物的全球市场规模将达到74亿美元，预测期内（2023-2030年）年复合成长率为5.4%。

报告范围		报告详情
基准年	2022年	2023年市场规模	74亿美元
实绩资料	2018-2021	预测期	2023-2030
预测期年复合成长率	5.40%	2030年市场规模预测	107亿美元

图 1. 2023 年脊髓损伤药物的全球市场占有率（%）（按适应症）

脊髓损伤是 31 对脊椎神经的损伤，这些脊椎神经将神经讯号从大脑传送到身体的各个部位，并控製手臂和腿部的发育。脊髓损伤的基本原因包括损伤、脊髓血液供应丧失、癌症或污染压迫脊髓。脊髓损伤可以藉助各种方法来确定，例如 X 光、磁混响记录 (MRI)、图形断层扫描 (CT)。製药业的主要公司都专注于开发与治疗脊髓损伤相关的药物。因此，在市场上引入此类先进产品预计将在预测期内推动全球脊髓损伤治疗市场的成长。

市场动态

製药业的主要公司都致力于开发新药。因此，在市场上引入此类先进产品预计将在预测期内推动全球脊髓损伤治疗市场的成长。例如，2022 年 6 月，完全一体化的基本药物公司 Amneal Pharmaceuticals, Inc. 获得美国食品药物管理局(FDA)核准用于治疗与多发性硬化症和其他脊椎疾病相关的痉挛，并宣布 LYVISPAH商业性上市，一种专门的巴氯芬口服颗粒（5、10、20 毫克）产品。

本研究的主要特点

• 本报告对全球脊髓损伤治疗药物市场进行了详细分析，并提出了以2022年为基准年的预测期（2023-2030）的市场规模和復合年度（年复合成长率）。它还强调了各个细分市场的潜在收益成长机会，并为该市场说明了一系列有吸引力的投资提案。
• 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的主要考察。
• 根据公司亮点、产品系列、主要亮点、绩效和策略等参数对全球脊髓损伤药物市场的主要参与者进行了分析。
• 本研究涵盖的主要企业包括Teva Pharmaceutical Industries Ltd.、AbbVie Inc.、Pfizer Inc.、Reddy's Laboratories Ltd.、Zydus Cadila、ReNetX Bio, Inc.、InVivo Therapeutics Holdings、Lineage Cell Therapeutics, Inc.、Kringle Pharma, Inc . 、NervGen、Rising Pharmaceuticals、ScieGen Pharmaceuticals、MSN Laboratories Private Limited、Lannett Co Inc.
• 该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出明智的资讯。
• 全球脊髓损伤治疗药物市场报告针对该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
• 透过用于分析全球脊髓损伤药物市场的各种策略矩阵，将有助于相关人员做出决策。

目录

第1章调查目的和假设

• 这项研究的目的
• 假设
• 简称

第2章市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第3章市场动态、法规及趋势分析

• 市场动态
  • 促进因素
  • 抑制因素
  • 市场机会
• 影响分析
• 最近测试启动
• 流行病学
• 合併、收购和合作
• 法规场景
• 主要进展
• PEST分析

第4章全球脊髓损伤治疗药物市场-新型冠状病毒感染疾病（COVID-19）的影响分析

• 经济影响
• 新型冠状病毒感染疾病（COVID-19）的流行病学
• 对需求和供给的影响

第5章全球脊髓损伤药物市场，依药物类型，2018-2030

• 皮质类固醇
• 肌肉鬆弛剂和抗惊厥药
• 非类固醇消炎剂(NSAID'S)
• 抗忧郁症
• 抗惊厥药
• 其他的

第6章2018-2030 年全球脊髓损伤药物市场（依适应症）

• 完全性脊髓损伤
• 不完全性脊髓损伤

第7章2018-2030年全球脊髓损伤药物市场（依应用）

• 自主神经失衡（AD）
• 痉挛和发炎
• 疼痛管理
• 沮丧

第8章全球脊髓损伤药物市场（依给药途径），2018-2030 年

• 口服
• 静脉

第9章全球脊髓损伤药物市场，依配销通路，2018-2030

• 医院药房
• 零售药房
• 网路药房

第10章2018-2030年全球脊髓损伤药物市场（按地区）

• 北美洲
• 美国
• 加拿大
• 欧洲
• 英国
• 德国
• 义大利
• 法国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 中国
• 印度
• 日本
• ASEAN
• 澳洲
• 韩国
• 其他亚太地区
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲
• 中东
• GCC
• 以色列
• 其他中东地区
• 非洲
• 北非
• 中部非洲
• 南非

第11章竞争形势

• 公司简介
  • Teva Pharmaceutical Industries Ltd.
  • AbbVie Inc
  • Pfizer Inc.
  • Reddy's Laboratories Ltd
  • Zydus Cadila
  • ReNetX Bio, Inc
  • InVivo Therapeutics Holdings
  • Lineage Cell Therapeutics, Inc
  • Kringle Pharma, Inc.
  • Acorda Therapeutics, Inc.
  • Bioaxone Biosciences, Inc
  • RespireRx Pharmaceuticals Inc.
  • NervGen
  • Rising Pharmaceuticals, Inc
  • ScieGen Pharmaceuticals, Inc
  • MSN Laboratories Private Limited
  • Lannett Co Inc.
  • Other Prominent Players

第12章章节

• 参考
• 调查方法

The Global Spinal Cord Injury Therapeutics Market is estimated to be valued at US$ 7.4 billion in 2023 and is expected to exhibit a CAGR of 5.4% during the forecast period (2023-2030).

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 7.4 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	5.40%	2030 Value Projection:	US$ 10.7 Bn

Figure 1. Global Spinal Cord Injury Therapeutics Market Share (%), By Indication, 2023

Spinal cord wounds are the wounds caused to the 31 sets of spinal nerves, which convey nerve signals from the mind to different parts of the body and likewise control the arm and leg developments. The fundamental driver of spinal cord wounds incorporate injury, loss of blood supply to the spinal cord, and pressure in the spinal cord because of cancer or contamination. Spinal cord wounds can be determined to have the assistance of different methods, for example, X-beam, attractive reverberation record (MRI), and figured tomography (CT). Key players in the pharmaceutical industry are focusing on the development of drugs associated with the treatment of spinal cord injuries. Thus, the introduction of such advanced products in the market is expected to drive the growth of the global spinal cord injury therapeutics market over the forecast period.

Market Dynamics

The key players in the pharmaceutical industry are focusing on the development of new drugs for spinal cord injury treatment. Thus, the introduction of such advanced products in the market is expected to drive growth of the global spinal cord injury therapeutics market over the forecast period. For instance, in June 2022, Amneal Pharmaceuticals, Inc., a fully integrated essential medicines company, announced the commercial launch of LYVISPAH, a baclofen oral granules (5, 10 and 20 mg) specialty product approved by the U.S. Food and Drug Administration (FDA) for the treatment of spasticity related to multiple sclerosis and other spinal cord disorders.

Key features of the study:

• This report provides an in-depth analysis of the global spinal cord injury therapeutics market and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year. It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global spinal cord injury therapeutics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• The key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., AbbVie Inc, Pfizer Inc., Reddy's Laboratories Ltd, Zydus Cadila, ReNetX Bio, Inc, InVivo Therapeutics Holdings, Lineage Cell Therapeutics, Inc, Kringle Pharma, Inc., Acorda Therapeutics, Inc., Bioaxone Biosciences, Inc, RespireRx Pharmaceuticals Inc., NervGen, Rising Pharmaceuticals, Inc, ScieGen Pharmaceuticals, Inc, MSN Laboratories Private Limited, and Lannett Co Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global spinal cord injury therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global spinal cord injury therapeutics market

Global Spinal Cord Injury Therapeutics Market Detailed Segmentation:

• By Drug Type:
  • Corticosteroids
  • Muscle Relaxants and Anti-spastic drugs
  • Non-steroidal Anti-inflammatory drugs (NSAID'S)
  • Anti-depressants
  • Anticonvulsants
  • Others
• By Indication:
  • Complete Spinal Cord Injury
  • Incomplete Spinal Cord Injury
• By Application:
  • Autonomic Dysreflexia (AD)
  • Spasticity and Inflammation
  • Pain Management
  • Depression
• By Route of Administration:
  • Oral
  • Intravenous
• By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles
  • Teva Pharmaceutical Industries Ltd.
  • AbbVie Inc
  • Pfizer Inc.
  • Reddy's Laboratories Ltd
  • Zydus Cadila
  • ReNetX Bio, Inc
  • InVivo Therapeutics Holdings
  • Lineage Cell Therapeutics, Inc
  • Kringle Pharma, Inc.
  • Acorda Therapeutics, Inc.
  • Bioaxone Biosciences, Inc
  • RespireRx Pharmaceuticals Inc.
  • NervGen
  • Rising Pharmaceuticals, Inc
  • ScieGen Pharmaceuticals, Inc
  • MSN Laboratories Private Limited
  • Lannett Co Inc.
  • Other Prominent Players

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Drug Type
  • Market Snippet, By Indication
  • Market Snippet, By Application
  • Market Snippet, By Route of Administration
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Recent Test Launches
• Epidemiology
• Merger, Acquisition, and Collaborations
• Regulatory Scenario
• Key Developments
• PEST Analysis

4. Global Spinal Cord Injury Therapeutics Market - COVID-19 Impact Analysis

• Economic Impact
• COVID-19 Epidemiology
• Impact on Supply and Demand

5. Global Spinal Cord Injury Therapeutics Market, By Drug Type, 2018 - 2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Corticosteroids
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Muscle Relaxants and Anti-spastic Drugs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Non-steroidal Anti-inflammatory Drugs (NSAID'S)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Anti-depressants
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Anticonvulsants
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends

6. Global Spinal Cord Injury Therapeutics Market, By Indication, 2018 - 2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Complete Spinal Cord Injury
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Incomplete Spinal Cord Injury
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends

7. Global Spinal Cord Injury Therapeutics Market, By Application, 2018 - 2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Autonomic Dysreflexia (AD)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Spasticity and Inflammation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Pain Management
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Depression
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends

8. Global Spinal Cord Injury Therapeutics Market, By Route of Administration, 2018 - 2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Intravenous
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends

9. Global Spinal Cord Injury Therapeutics Market, By Distribution Channel, 2018 - 2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  • Segment Trends

10. Global Spinal Cord Injury Therapeutics Market, By Region, 2018 - 2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 - 2030, (US$ Bn
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 - 2030, (US$ Bn
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 - 2030, (US$ Bn
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 - 2030, (US$ Bn
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 - 2030, (US$ Bn
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 - 2030, (US$ Bn
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn
  • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2018 - 2030, (US$ Bn)
• North Africa
• Central Africa
• South Africa

11. Competitive Landscape

• Company Profiles
  • Teva Pharmaceutical Industries Ltd.
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
  • AbbVie Inc
  • Pfizer Inc.
  • Reddy's Laboratories Ltd
  • Zydus Cadila
  • ReNetX Bio, Inc
  • InVivo Therapeutics Holdings
  • Lineage Cell Therapeutics, Inc
  • Kringle Pharma, Inc.
  • Acorda Therapeutics, Inc.
  • Bioaxone Biosciences, Inc
  • RespireRx Pharmaceuticals Inc.
  • NervGen
  • Rising Pharmaceuticals, Inc
  • ScieGen Pharmaceuticals, Inc
  • MSN Laboratories Private Limited
  • Lannett Co Inc.
  • Other Prominent Players

12. Section

• References
• Research Methodology
• About us and Sales Contact